The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, Saint Regis Mohawk Tribe, Restasis, patent, patent agreement, Native Americans, inter partes review, sovereign immunity, Mylan, PTAB